NO992340L - Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel - Google Patents

Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Info

Publication number
NO992340L
NO992340L NO992340A NO992340A NO992340L NO 992340 L NO992340 L NO 992340L NO 992340 A NO992340 A NO 992340A NO 992340 A NO992340 A NO 992340A NO 992340 L NO992340 L NO 992340L
Authority
NO
Norway
Prior art keywords
cyclosporin
anionic surfactant
solid pharmaceutical
pharmaceutical compositions
disclosed
Prior art date
Application number
NO992340A
Other languages
English (en)
Norwegian (no)
Other versions
NO992340D0 (no
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Publication of NO992340D0 publication Critical patent/NO992340D0/no
Publication of NO992340L publication Critical patent/NO992340L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO992340A 1997-09-16 1999-05-14 Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel NO992340L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ328751A NZ328751A (en) 1997-09-16 1997-09-16 Solid medicament containing an anionic surfactant and cyclosporin
PCT/CA1998/000880 WO1999013900A1 (fr) 1997-09-16 1998-09-16 Compositions pharmaceutiques solides comprenant une ciclosporine et un tensioactif anionique

Publications (2)

Publication Number Publication Date
NO992340D0 NO992340D0 (no) 1999-05-14
NO992340L true NO992340L (no) 1999-07-06

Family

ID=19926445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992340A NO992340L (no) 1997-09-16 1999-05-14 Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Country Status (23)

Country Link
US (1) US6197335B1 (fr)
EP (1) EP0957931B1 (fr)
JP (1) JP2001505928A (fr)
KR (1) KR20000068991A (fr)
CN (1) CN1239432A (fr)
AR (1) AR013499A1 (fr)
AT (1) ATE214938T1 (fr)
AU (1) AU9149198A (fr)
BR (1) BR9806212A (fr)
CA (1) CA2271447A1 (fr)
CZ (1) CZ157099A3 (fr)
DE (1) DE69804429D1 (fr)
HU (1) HUP0000839A3 (fr)
ID (1) ID21683A (fr)
IL (1) IL129780A0 (fr)
NO (1) NO992340L (fr)
NZ (1) NZ328751A (fr)
PL (1) PL333353A1 (fr)
SI (1) SI9820010A (fr)
TR (1) TR199901070T1 (fr)
WO (1) WO1999013900A1 (fr)
YU (1) YU22399A (fr)
ZA (1) ZA988452B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
WO2003032949A1 (fr) * 2001-10-19 2003-04-24 Isotechnika Inc. Nouveaux preconcentres en microemulsion d'analogues de cyclosporine
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
EP3913375A1 (fr) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Dispositifs microfluidiques et procédés d'utilisation dans la formation et contrôle de nanoréacteurs
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2481815B1 (fr) 2006-05-11 2016-01-27 Raindance Technologies, Inc. Dispositifs microfluidiques
WO2008021123A1 (fr) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Tensioactifs fluorocarbonés stabilisateurs d'émulsions
WO2008097559A2 (fr) 2007-02-06 2008-08-14 Brandeis University Manipulation de fluides et de réactions dans des systèmes microfluidiques
WO2008130623A1 (fr) 2007-04-19 2008-10-30 Brandeis University Manipulation de fluides, composants fluidiques et réactions dans des systèmes microfluidiques
SG2013054218A (en) 2008-01-15 2014-10-30 Abbott Gmbh & Co Kg Powdered protein compositions and methods of making same
EP2262477A1 (fr) * 2008-03-04 2010-12-22 F. Hoffmann-La Roche AG Procédé de préparation de solutions micellaires aqueuses concentrées
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2011042564A1 (fr) 2009-10-09 2011-04-14 Universite De Strasbourg Nanomatériau marqué à base de silice à propriétés améliorées et ses utilisations
WO2011079176A2 (fr) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Systèmes microfluidiques et procédés pour réduire l'échange de molécules entre des gouttelettes
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP2622103B2 (fr) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Dosages sandwich dans des gouttelettes
EP3859011A1 (fr) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Procédés permettant de former des gouttelettes mélangées
WO2012112804A1 (fr) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions et méthodes de marquage moléculaire
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3709018A1 (fr) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Appareil microfluidique pour l'identification de composants d'une reaction chimique
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (fr) 2013-12-31 2015-07-09 Raindance Technologies, Inc. Système et procédé de détection d'une espèce d'arn
EP3091974B1 (fr) * 2014-01-06 2020-04-01 Shield TX (UK) Limited Schéma posologique de trimaltol ferrique
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
WO2019181876A1 (fr) * 2018-03-19 2019-09-26 大鵬薬品工業株式会社 Composition pharmaceutique comprenant du sulfate d'alkyle de sodium
TW202330014A (zh) * 2021-10-13 2023-08-01 日商中外製藥股份有限公司 含有胜肽化合物及界面活性劑之組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908722A (nl) 1979-12-03 1981-07-01 Naarden International Nv Werkwijze voor de bereiding van citrussap bevattende dranken met verbeterde troebelingsstabiliteit.
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
JPH0597697A (ja) * 1991-10-02 1993-04-20 Lion Corp 歯槽骨再生剤
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
IE75744B1 (en) * 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
JPH1059862A (ja) * 1996-08-16 1998-03-03 Meiji Seika Kaisha Ltd シクロスポリン製剤
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures

Also Published As

Publication number Publication date
NZ328751A (en) 1999-01-28
ATE214938T1 (de) 2002-04-15
JP2001505928A (ja) 2001-05-08
BR9806212A (pt) 2000-04-18
CA2271447A1 (fr) 1999-03-25
IL129780A0 (en) 2000-02-29
HUP0000839A3 (en) 2001-02-28
US6197335B1 (en) 2001-03-06
PL333353A1 (en) 1999-12-06
TR199901070T1 (xx) 1999-11-22
AR013499A1 (es) 2000-12-27
SI9820010A (sl) 1999-08-31
ID21683A (id) 1999-07-08
KR20000068991A (ko) 2000-11-25
YU22399A (sh) 2003-01-31
CZ157099A3 (cs) 1999-09-15
ZA988452B (en) 1999-03-30
HUP0000839A2 (hu) 2000-11-28
EP0957931B1 (fr) 2002-03-27
EP0957931A1 (fr) 1999-11-24
CN1239432A (zh) 1999-12-22
DE69804429D1 (de) 2002-05-02
WO1999013900A1 (fr) 1999-03-25
NO992340D0 (no) 1999-05-14
AU9149198A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
NO992340L (no) Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel
LU91122I2 (fr) Efalizumab et ses dérivés pharmaceutiquement acceptables (raptiva).
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
EP0828481A4 (fr) Composition administree par voie orale et destinee a etre liberee dans l'intestin et son procede d'utilisation
BG106030A (en) Pharmaceutical composition
NO20083842L (no) Anvendelse av opploselig lymfotoksin-beta-reseptor for fremstilling av medikamenter
DK0553191T3 (da) Pyridin- og pyridin-N-oxidderivater af diarylmethylpiperidiner eller -piperaziner, præparater og an vendelse deraf
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
HUT74474A (en) Pharmaceutical emulsion comprising a short acting dihydropyridine type antihypertensive agent
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
NO2010004I1 (no) 0,02 mg etinylostradiol (som betadexclathrat) og 3mg drospirenon
FI973691A (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
DK1119359T3 (da) 2-methyl-thieno-benzodiazepinformulering
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
PT1066304E (pt) Antagonistas macrolidos de lhrh
ATE213416T1 (de) Arzneizubereitungen enthaltend cefuroxim axetil
NZ506622A (en) 3',3'-N-bis-substituted macrolide LHRH antagonists
HRP20000704B1 (en) Controlled release peroral compositions of levosimendan
DK1091750T3 (da) Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ECSP982436A (es) Composicion
NO975526D0 (no) Nye laksativpreparater og fremgangsmåte for fremstilling av slike

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application